We are live on ! Find out more
EFM

E Fund Management Portfolio holdings

AUM $4.46B
This Fund
S&P 500
This Quarter Est. Return
+6.51%
1 Year Est. Return
–
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$1.95B
AUM Growth
+$137M
Cap. Flow
+$63.5M
Cap. Flow %
3.26%
Top 10 Hldgs %
62.7%
Holding
375
New
57
Increased
197
Reduced
86
Closed
22

Top Buys

Rank Stock Value
1
MSFT icon
Microsoft
MSFT
+$12.1M
2
AAPL icon
Apple
AAPL
+$11.7M
3
NVDA icon
NVIDIA
NVDA
+$9.16M
4
AVGO icon
Broadcom
AVGO
+$6.03M
5
PDD icon
Pinduoduo
PDD
+$5.45M

Top Sells

Rank Stock Value
1
ASX icon
ASE Group
ASX
+$18.3M
2
SE icon
Sea Limited
SE
+$11.3M
3
TSM icon
TSMC
TSM
+$9.27M
4
ZTO icon
ZTO Express
ZTO
+$7.08M
5
NIO icon
NIO
NIO
+$4.53M

Sector Composition

Rank Sector Weight
1 Consumer Discretionary 37.74%
2 Technology 30.94%
3 Communication Services 8.5%
4 Healthcare 6.31%
5 Financials 5.27%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
SVRA icon
351
Savara
SVRA
$1.09B
$45.8K ﹤0.01%
+10,802
New +$47.7K
ERAS icon
352
Erasca
ERAS
$6.38B
$40.7K ﹤0.01%
+14,917
New +$42K
SCLX icon
353
Scilex Holding
SCLX
$38.6M
$29.1K ﹤0.01%
898
– –
ASX icon
354
ASE Group
ASX
$98.3B
– –
-1,600,000
Closed -$18.3M
AVXL icon
355
Anavex Life Sciences
AVXL
$278M
– –
-13,623
Closed -$57.5K
CAMT icon
356
Camtek
CAMT
$6.34B
– –
-5,227
Closed -$655K
CCCC icon
357
C4 Therapeutics
CCCC
$477M
– –
-11,280
Closed -$52.1K
CLDX icon
358
Celldex Therapeutics
CLDX
$3.12B
– –
-7,258
Closed -$269K
COGT icon
359
Cogent Biosciences
COGT
$6.07B
– –
-11,173
Closed -$94.2K
CPRX
360
DELISTED
Catalyst Pharmaceutical
CPRX
– –
-11,266
Closed -$175K
DLTR icon
361
Dollar Tree
DLTR
$24.3B
– –
-2,147
Closed -$229K
EDIT icon
362
Editas Medicine
EDIT
$510M
– –
-13,051
Closed -$60.9K
EZU icon
363
iShare MSCI Eurozone ETF
EZU
$9.87B
– –
-4,640
Closed -$227K
HRTX icon
364
Heron Therapeutics
HRTX
$62M
– –
-15,642
Closed -$54.7K
IBN icon
365
ICICI Bank
IBN
$107B
– –
-35,624
Closed -$1.03M
NIO icon
366
NIO
NIO
$10.9B
– –
-1,089,571
Closed -$4.53M
OEF icon
367
iShares S&P 100 ETF
OEF
$20.5B
– –
-3,798
Closed -$1M
SE icon
368
Sea Limited
SE
$73B
– –
-158,000
Closed -$11.3M
TVTX icon
369
Travere Therapeutics
TVTX
$6.21B
– –
-11,071
Closed -$91K
VOO icon
370
Vanguard S&P 500 ETF
VOO
$1.03T
– –
-1,940
Closed -$970K
VV icon
371
Vanguard Morningstar Large-Cap ETF
VV
$54.3B
– –
-4,074
Closed -$1.02M
ZNTL icon
372
Zentalis Pharmaceuticals
ZNTL
$353M
– –
-10,177
Closed -$41.6K
ZTO icon
373
ZTO Express
ZTO
$16.4B
– –
-341,040
Closed -$7.08M
CDMO
374
DELISTED
Avid Bioservices, Inc. Common Stock
CDMO
– –
-11,194
Closed -$79.9K
CERE
375
DELISTED
Cerevel Therapeutics Holdings, Inc. Common Stock
CERE
– –
-11,132
Closed -$455K
11 12 13 14
15

Similar funds

ACM
Advent Capital Management New York $4.46B AUM 0.73% 1-Year Est. Return
HCM
Hamlin Capital Management New York $4.45B AUM 22.95% 1-Year Est. Return
MAM
Magellan Asset Management Sydney, Australia $4.47B AUM 4.2% 1-Year Est. Return
AP
Americana Partners Houston, Texas $4.44B AUM 29.45% 1-Year Est. Return
BP
BC Partners New York $4.43B AUM 49.12% 1-Year Est. Return
WSFS
Wilmington Savings Fund Society Wilmington, Delaware $4.48B AUM 24.77% 1-Year Est. Return
AOI
Auto-Owners Insurance Lansing, Michigan $4.43B AUM 30.05% 1-Year Est. Return
WA
WestEnd Advisors Charlotte, North Carolina $4.49B AUM 19.44% 1-Year Est. Return

E Fund Management's Q3 2024 Portfolio in Review

As of Q3 2024, E Fund Management held 375 positions worth $1.95B, up 7.6% from $1.81B the previous quarter. Its ten largest holdings account for 63% of the portfolio.

E Fund Management deployed $63.5M of net new capital in Q3 2024, opening 57 new positions and adding to 197 existing holdings. Its largest new stake was argenx: 5,800 shares worth $3.14M.

By sector, the portfolio is most concentrated in Consumer Discretionary at 38% of assets, down from 40% a quarter earlier, followed by Technology and Communication Services.

On the sell side, the largest reduction was TSMC, an estimated $9.27M trimmed.

  • E Fund Management's largest Q3 2024 buy was argenx: 5,800 shares worth $3.14M.
  • E Fund Management added most to Microsoft in Q3 2024, an estimated $12.1M increase.
  • E Fund Management's biggest Q3 2024 reduction was TSMC, cutting an estimated $9.27M.
  • E Fund Management fully exited ASE Group in Q3 2024, selling an estimated $18.3M.
  • E Fund Management's ten largest holdings make up 63% of its $1.95B portfolio in Q3 2024.
  • E Fund Management opened 57 new positions and closed 22 in Q3 2024.
  • E Fund Management's portfolio value rose 7.6% quarter-over-quarter to $1.95B.

Based on E Fund Management's 13F filing for Q3 2024, filed 13 Nov 2024.